James Blackshaw

James Blackshaw

Auto-generated profile, based on publicly available information

James Blackshaw

EMBL-EBI

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in Nature
Verified
Journal Article
Open access
PDF file
BSBenjamin B. Sun
Benjamin B. Sun
JMJoseph C. Maranville
Joseph C. Maranville
JPJames E. Peters
James E. Peters
DSDavid Stacey
David Stacey
JSJames R. Staley
James R. Staley
ABAdam S. Butterworth
Adam S. Butterworth
Although plasma proteins have important roles in biological processes and are the direct targets of many drugs, the genetic factors that control inter-individual variation in plasma protein levels are not well understood. Here we characterize the genetic architecture of the human plasma proteome in healthy blood donors from the INTERVAL study. We identify 1,927 genetic associations with 1,478 proteins, a fourfold increase on existing knowledge, including trans associations for 1,104 proteins. To understand the consequences of perturbations in plasma protein levels, we apply an integrated approach that links genetic variation with biological pathway, disease, and drug databases. We show that protein quantitative trait loci overlap with gene expression quantitative trait loci, as well as with disease-associated loci, and find evidence that protein biomarkers have causal roles in disease using Mendelian randomization analysis. By linking genetic factors to diseases via specific proteins, our analyses highlight potential therapeutic targets, opportunities for matching existing drugs with new disease indications, and potential safety concerns for drugs under development.

24 June 2019 in Bioinformatics
Verified
Journal Article
Open access
MKMihir A Kamat
Mihir A Kamat
JBJames A Blackshaw
James A Blackshaw
RYRobin Young
Robin Young
PSPraveen Surendran
Praveen Surendran
SBStephen Burgess
Stephen Burgess
JSJames R Staley
James R Staley
Summary: PhenoScanner is a curated database of publicly available results from large-scale genetic association studies in humans. This online tool facilitates ‘phenome scans’, where genetic variants are cross-referenced for association with many phenotypes of different types. Here we present a major update of PhenoScanner (‘PhenoScanner V2’), including over 150 million genetic variants and more than 65 billion associations (compared to 350 million associations in PhenoScanner V1) with diseases and traits, gene expression, metabolite and protein levels, and epigenetic markers. The query options have been extended to include searches by genes, genomic regions and phenotypes, as well as for genetic variants. All variants are positionally annotated using the Variant Effect Predictor and the phenotypes are mapped to Experimental Factor Ontology terms. Linkage disequilibrium statistics from the 1000 Genomes project can be used to search for phenotype associations with proxy variants. Availability and implementation: PhenoScanner V2 is available at www.phenoscanner.medschl.cam.ac.uk.

17 June 2016 in Bioinformatics
Verified
Journal Article
Open access
PDF file
JSJames R. Staley
James R. Staley
JBJames Blackshaw
James Blackshaw
MKMihir A. Kamat
Mihir A. Kamat
SESteve Ellis
Steve Ellis
PSPraveen Surendran
Praveen Surendran
ABAdam S. Butterworth
Adam S. Butterworth
Summary: PhenoScanner is a curated database of publicly available results from large-scale genetic association studies. This tool aims to facilitate ‘phenome scans’, the cross-referencing of genetic variants with many phenotypes, to help aid understanding of disease pathways and biology. The database currently contains over 350 million association results and over 10 million unique genetic variants, mostly single nucleotide polymorphisms. It is accompanied by a web-based tool that queries the database for associations with user-specified variants, providing results according to the same effect and non-effect alleles for each input variant. The tool provides the option of searching for trait associations with proxies of the input variants, calculated using the European samples from 1000 Genomes and Hapmap. Availability and Implementation: PhenoScanner is available at www.phenoscanner.medschl.cam.ac.uk. Contact:jrs95@medschl.cam.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.

24 November 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ASAnthony C. Smith
Anthony C. Smith
JBJames A. Blackshaw
James A. Blackshaw
ARAlan J. Robinson
Alan J. Robinson
MitoMiner (http://mitominer.mrc-mbu.cam.ac.uk/) is a data warehouse for the storage and analysis of mitochondrial proteomics data gathered from publications of mass spectrometry and green fluorescent protein tagging studies. In MitoMiner, these data are integrated with data from UniProt, Gene Ontology, Online Mendelian Inheritance in Man, HomoloGene, Kyoto Encyclopaedia of Genes and Genomes and PubMed. The latest release of MitoMiner stores proteomics data sets from 46 studies covering 11 different species from eumetazoa, viridiplantae, fungi and protista. MitoMiner is implemented by using the open source InterMine data warehouse system, which provides a user interface allowing users to upload data for analysis, personal accounts to store queries and results and enables queries of any data in the data model. MitoMiner also provides lists of proteins for use in analyses, including the new MitoMiner mitochondrial proteome reference sets that specify proteins with substantial experimental evidence for mitochondrial localization. As further mitochondrial proteomics data sets from normal and diseased tissue are published, MitoMiner can be used to characterize the variability of the mitochondrial proteome between tissues and investigate how changes in the proteome may contribute to mitochondrial dysfunction and mitochondrial-associated diseases such as cancer, neurodegenerative diseases, obesity, diabetes, heart failure and the ageing process.

5 May 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBenjamin B. Sun
Benjamin B. Sun
JMJoseph C. Maranville
Joseph C. Maranville
JPJames E. Peters
James E. Peters
DSDavid Stacey
David Stacey
JSJames R. Staley
James R. Staley
ABAdam S. Butterworth
Adam S. Butterworth
Proteins are the primary functional units of biology and the direct targets of most drugs, yet there is limited knowledge of the genetic factors determining inter-individual variation in protein levels. Here we reveal the genetic architecture of the human plasma proteome, testing 10.6 million DNA variants against levels of 2,994 proteins in 3,301 individuals. We identify 1,927 genetic associations with 1,478 proteins, a 4-fold increase on existing knowledge, including trans associations for 1,104 proteins. To understand consequences of perturbations in plasma protein levels, we introduce an approach that links naturally occurring genetic variation with biological, disease, and drug databases. We provide insights into pathogenesis by uncovering the molecular effects of disease-associated variants. We identify causal roles for protein biomarkers in disease through Mendelian randomization analysis. Our results reveal new drug targets, opportunities for matching existing drugs with new disease indications, and potential safety concerns for drugs under development.

23 September 2009
Verified
Dataset
Open access
JBJames Blackshaw
James Blackshaw
AGAnna Gaulton
Anna Gaulton
ABA. Patrícia Bento
A. Patrícia Bento
MVMarleen De Veij
Marleen De Veij
DLDavid Mendez Lopez
David Mendez Lopez
RTRicardo Arcila Toro
Ricardo Arcila Toro